Study suggests that a liquid LT4 formulation ca... - Thyroid UK

Thyroid UK

137,936 members161,765 posts

Study suggests that a liquid LT4 formulation can be ingested directly at breakfast

realturbo profile image
2 Replies

"The TICO study suggests that a liquid LT4 formulation can be ingested directly at breakfast, thus potentially improving therapeutic compliance. This observation is of considerable clinical relevance, since non-adherence to LT4 therapy requirements is more likely to cause variability in serum TSH concentrations."

online.liebertpub.com/doi/a...

Written by
realturbo profile image
realturbo
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Clutter profile image
Clutter

Realturbo, liquid thyroxine is rarely prescribed as it is very expensive compared to Levothyroxine tablets. It's only likely to be prescribed to patients allergic to the fillers in Levothyroxine tablets.

_______________________________________________________________________________

I am not a medical professional and this information is not intended to be a substitute for medical guidance from your own doctor. Please check with your personal physician before applying any of these suggestions.

realturbo profile image
realturbo in reply to Clutter

That;s true Clutter, I wonder if the same conclusion might apply to taking LT4 in tablet form...

You may also like...

Liquid T4 is a better controller than tablet

and therapeutic effects might be affected by many factors. Data shows that therapy with liquid LT4...

Levothyroxine dosage and the limitations of current bioequivalence standards

optimize therapeutic outcomes and assure patient safety. FDA regulation of LT4 formulations aims to...

A couple of new papers of interest

TUK. THYROID Volume 31, Number 5, 2021 DOI: 10.1089/thy.2020.0388 Liothyronine Use in...

Endo fixated with suppressed TSH

pmol/L [11-26] FT3 2.7 pmol/L [3-6] I am on 75mcg LT4/ 20mcg LT3... the last two blood results have...

Optimizing the treatment of hypothyroidism

Bianco & Peter N. Taylor Daily levothyroxine (LT4) is the standard of care for the...